Cargando…
The PARTHENON Clinical Development Program: the Role of Ticagrelor in Patients with Atherothrombotic Disease
Although the rate of cardiovascular disease (CVD)-related mortality has declined over the last decade, it is still the leading cause of mortality in the USA, accounting for over 1.4 million deaths annually. In addition, total direct (primarily hospital admissions) and indirect costs of CVD in the US...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591813/ https://www.ncbi.nlm.nih.gov/pubmed/28866767 http://dx.doi.org/10.1007/s10557-017-6749-7 |